These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15506343)

  • 1. [Natriuretic peptides in patients with heart failure].
    Horii M; Saito Y
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():84-7. PubMed ID: 15506343
    [No Abstract]   [Full Text] [Related]  

  • 2. Natriuretic peptides: biochemistry, physiology, and therapeutic role in heart failure.
    Stoupakis G; Klapholz M
    Heart Dis; 2003; 5(3):215-23. PubMed ID: 12783635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biomarkers in heart failure: are they clinically useful?].
    Kempf T; Wollert KC
    Dtsch Med Wochenschr; 2009 Apr; 134(15):740-6. PubMed ID: 19340752
    [No Abstract]   [Full Text] [Related]  

  • 4. Usefulness of B-type natriuretic peptide levels in predicting hemodynamic and clinical decompensation.
    Taub PR; Daniels LB; Maisel AS
    Heart Fail Clin; 2009 Apr; 5(2):169-75. PubMed ID: 19249686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma brain natriuretic peptide-guided therapy not yet justified.
    Hoppe UC
    J Am Coll Cardiol; 2007 Nov; 50(21):2097-8; author reply 2098-9. PubMed ID: 18021882
    [No Abstract]   [Full Text] [Related]  

  • 6. [Heart failure in patients with hypertension].
    Yoshimura M
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():347-51. PubMed ID: 15171397
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pathophysiology of congestive heart failure].
    Luzza F; Bruni F; Rizzo F; Carerj S
    Minerva Cardioangiol; 2002 Jun; 50(3):209-19. PubMed ID: 12107401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormones and hemodynamics in heart failure.
    Schrier RW; Abraham WT
    N Engl J Med; 1999 Aug; 341(8):577-85. PubMed ID: 10451464
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hypertension in patients with heart failure].
    Takekoshi N; Asaji T; Tada N
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():478-83. PubMed ID: 15171419
    [No Abstract]   [Full Text] [Related]  

  • 10. [Recommendations for the clinical use of cardiac natriuretic peptides].
    Emdin M; Clerico A; Clemenza F; Galvani M; Latini R; Masson S; Mulè P; Panteghini M; Valle R; Zaninotto M; Ganau A; Mariotti R; Volpe M; Aspromonte N; Cacciatore G; Cappelletti P; L'Abbate A; Miglio F; Ottani F; Pagani F; Passino C; Plebani M; Sarzani R; Zucchelli G
    Ital Heart J Suppl; 2005 May; 6(5):308-25. PubMed ID: 15934430
    [No Abstract]   [Full Text] [Related]  

  • 11. Value of BNP to estimate cardiac risk in patients on cardioactive treatment in primary care.
    Nielsen OW; Cowburn PJ; Sajadieh A; Morton JJ; Dargie H; McDonagh T
    Eur J Heart Fail; 2007 Dec; 9(12):1178-85. PubMed ID: 18062902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical agents acting on the renin-angiotensin-aldosterone axis for the treatment of heart failure.
    Kawano H; Node K
    Hypertens Res; 2010 Mar; 33(3):192-3. PubMed ID: 20203682
    [No Abstract]   [Full Text] [Related]  

  • 13. [Peripheral and cardiac adaptive mechanisms in heart failure: the role of the renin-angiotensin system and its inhibition].
    Drexler H
    Verh Dtsch Ges Inn Med; 1991; 97():552-7. PubMed ID: 1808945
    [No Abstract]   [Full Text] [Related]  

  • 14. [Renin-angiotensin system as a potential target for the treatment with heart failure: ACE inhibitors, angiotensin-II receptor blockers and aldosterone antagonists].
    Sanada S; Kitakaze M
    Nihon Rinsho; 2003 May; 61(5):821-6. PubMed ID: 12755009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pro: Natriuretic peptides as diagnostic tool. The analysis should be a routine in heart failure diagnosis].
    Dahlström U; Alehagen U
    Lakartidningen; 2006 Mar 22-28; 103(12):927-9. PubMed ID: 16618036
    [No Abstract]   [Full Text] [Related]  

  • 16. High prevalence of microalbuminuria in chronic heart failure patients.
    van de Wal RM; Asselbergs FW; Plokker HW; Smilde TD; Lok D; van Veldhuisen DJ; van Gilst WH; Voors AA
    J Card Fail; 2005 Oct; 11(8):602-6. PubMed ID: 16230263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congenital heart disease, exercise capacity and B-type natriuretic peptide.
    Carvalho VO
    Cardiol J; 2009; 16(5):489; author reply 490. PubMed ID: 19753535
    [No Abstract]   [Full Text] [Related]  

  • 18. [Efficacy of angiotensin II receptor antagonists as a novel drug for the treatment of chronic heart failure--in comparison with ACE inhibitors].
    Kitakaze M; Kuzuya T; Hori M
    Nihon Rinsho; 1999 May; 57(5):1148-57. PubMed ID: 10361449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natriuretic peptides and heart failure.
    McLachlan CS; Yu H; Mossop P
    CMAJ; 2007 Feb; 176(5):659. PubMed ID: 17325337
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effects of angiotensin converting enzyme inhibitor with different doses on plasma brain natriuretic peptide and norepinephrine in patients with chronic heart failure].
    Song HM; Zhang J; Deng B; Luo M
    Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(25):1737-40. PubMed ID: 16253158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.